{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T17:31:16Z","timestamp":1773682276029,"version":"3.50.1"},"reference-count":72,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","neurologic.theclinics.com","clinicalkey.es","theclinics.com","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurologic Clinics"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/j.ncl.2015.08.010","type":"journal-article","created":{"date-parts":[[2015,11,24]],"date-time":"2015-11-24T20:51:52Z","timestamp":1448398312000},"page":"235-246","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Cognitive and Psychiatric Disturbances in Parkinsonian Syndromes"],"prefix":"10.1016","volume":"34","author":[{"given":"Richard M.","family":"Zweig","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth A.","family":"Disbrow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vijayakumar","family":"Javalkar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ncl.2015.08.010_bib1","doi-asserted-by":"crossref","first-page":"S85","DOI":"10.1016\/S1353-8020(13)70022-1","article-title":"Modeling Lewy pathology propagation in Parkinson\u2019s disease","volume":"20","author":"Luk","year":"2014","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.ncl.2015.08.010_bib2","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/0166-2236(90)90107-L","article-title":"Functional architecture of basal ganglia circuits: neural substrates of parallel processing","volume":"13","author":"Alexander","year":"1990","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.ncl.2015.08.010_bib3","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1152\/jn.1985.53.2.530","article-title":"Primate globus pallidus and subthalamic nucleus: functional organization","volume":"53","author":"Delong","year":"1985","journal-title":"J\u00a0Neuropysiol"},{"key":"10.1016\/j.ncl.2015.08.010_bib4","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.expneurol.2009.12.030","article-title":"Somatotopic organization in the internal segment of the globus pallidus in Parkinson\u2019s disease","volume":"222","author":"Baker","year":"2010","journal-title":"Exp Neurol"},{"key":"10.1016\/j.ncl.2015.08.010_bib5","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3389\/fnsys.2011.00038","article-title":"Loss of specificity in basal ganglia related movement disorders","volume":"5","author":"Bronfeld","year":"2011","journal-title":"Front Syst Neurosci"},{"key":"10.1016\/j.ncl.2015.08.010_bib6","doi-asserted-by":"crossref","first-page":"e16293","DOI":"10.1371\/journal.pone.0016293","article-title":"Dispersed activity during passive movement in the globus pallidus of the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated primate","volume":"6","author":"Erez","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.ncl.2015.08.010_bib7","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1152\/jn.2000.83.3.1760","article-title":"Ratio of inhibited-to-activated pallidal neurons decreases dramatically during passive limb movement in the MPTP-treated monkey","volume":"83","author":"Boraud","year":"2000","journal-title":"J\u00a0Neurophysiol"},{"key":"10.1016\/j.ncl.2015.08.010_bib8","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1152\/jn.2001.86.1.249","article-title":"Effects of apomorphine on subthalamic nucleus and globus pallidus internus neurons in patients with Parkinson\u2019s disease","volume":"86","author":"Levy","year":"2001","journal-title":"J\u00a0Neurophysiol"},{"key":"10.1016\/j.ncl.2015.08.010_bib9","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1038\/nn.3997","article-title":"Therapeutic deep brain stimulation reduces cortical phase-amplitude coupling in Parkinson\u2019s disease","volume":"18","author":"De Hemptinne","year":"2015","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.ncl.2015.08.010_bib10","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","article-title":"Mutation in the alpha-synuclein gene identified in families with Parkinson\u2019s disease","volume":"276","author":"Polymeropoulos","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.ncl.2015.08.010_bib11","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/42166","article-title":"Alpha-synuclein in Lewy bodies","volume":"388","author":"Spillantini","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.ncl.2015.08.010_bib12","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00441-004-0956-9","article-title":"Stages in the development of Parkinson\u2019s disease-related pathology","volume":"318","author":"Braak","year":"2004","journal-title":"Cell Tissue Res"},{"key":"10.1016\/j.ncl.2015.08.010_bib13","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s11910-013-0373-0","article-title":"Parkinson disease and sleep: sleep-wake changes in the premotor stage of Parkinson disease; impaired olfaction and other prodromal features","volume":"13","author":"Iranzo","year":"2013","journal-title":"Curr Neurol Neurosci Rep"},{"key":"10.1016\/j.ncl.2015.08.010_bib14","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1002\/mds.25979","article-title":"Enteric glial cells: new players in Parkinson\u2019s disease?","volume":"30","author":"Clairembault","year":"2015","journal-title":"Mov Disord"},{"key":"10.1016\/j.ncl.2015.08.010_bib15","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1212\/WNL.0000000000000879","article-title":"Parkinson disease and smoking revisited: ease of quitting is an early sign of the disease","volume":"83","author":"Ritz","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2015.08.010_bib16","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1159\/000068483","article-title":"Neuropsychological profile of patients with Parkinson\u2019s disease without dementia","volume":"15","author":"Janvin","year":"2003","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.1016\/j.ncl.2015.08.010_bib17","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1002\/mds.25853","article-title":"Cognitive deficits in Parkinson\u2019 disease: a cognitive neuroscience perspective","volume":"29","author":"Robins","year":"2014","journal-title":"Mov Disord"},{"key":"10.1016\/j.ncl.2015.08.010_bib18","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1016\/S0028-3932(03)00117-9","article-title":"L-DOPA medication remediates cognitive inflexibility, but increases impulsivity in patients with Parkinson\u2019s disease","volume":"41","author":"Cools","year":"2003","journal-title":"Neuropsychologia"},{"key":"10.1016\/j.ncl.2015.08.010_bib19","first-page":"181","article-title":"Movement activation and inhibition in Parkinson\u2019s disease: a functional imaging study","volume":"3","author":"Disbrow","year":"2013","journal-title":"J\u00a0Parkinsons Dis"},{"key":"10.1016\/j.ncl.2015.08.010_bib20","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.neuropsychologia.2009.01.002","article-title":"Switching between abstract rules reflects disease severity but not dopaminergic status in Parkinson\u2019s disease","volume":"47","author":"Kehagia","year":"2009","journal-title":"Neuropsychologia"},{"key":"10.1016\/j.ncl.2015.08.010_bib21","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1523\/JNEUROSCI.4860-03.2004","article-title":"Neural basis of setshifting deficits in Parkinson\u2019s disease","volume":"24","author":"Monchi","year":"2004","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.ncl.2015.08.010_bib22","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1016\/j.neuropsychologia.2005.03.024","article-title":"Dopamine dependency of intradimensional and extradimensional switching operations in Parkinson\u2019s patients","volume":"43","author":"Shook","year":"2005","journal-title":"Neuropsychologia"},{"key":"10.1016\/j.ncl.2015.08.010_bib23","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1146\/annurev.ne.09.030186.002041","article-title":"Parallel organization of functionally segregated circuits linking basal ganglia and cortex","volume":"9","author":"Alexander","year":"1986","journal-title":"Annu Rev Neurosci"},{"key":"10.1016\/j.ncl.2015.08.010_bib24","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1007\/BF02245167","article-title":"L-dopa withdrawal in Parkinson\u2019s disease selectively impairs cognitive performance in tests sensitive frontal lobe dysfunction","volume":"107","author":"Lange","year":"1992","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ncl.2015.08.010_bib25","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1212\/WNL.46.1.231","article-title":"[1231] beta-CIT\/SPECT imaging demonstrates bilateral loss of dopamine transporters in hemi-Parkinson\u2019s disease","volume":"46","author":"Marek","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2015.08.010_bib26","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1212\/WNL.17.5.427","article-title":"Parkinsonism: onset, progression and mortality","volume":"17","author":"Hoehn","year":"1967","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2015.08.010_bib27","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.nbd.2011.12.041","article-title":"Psychosis, apathy, depression and anxiety in Parkinson\u2019s disease","volume":"46","author":"Gallager","year":"2012","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.ncl.2015.08.010_bib28","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1136\/jnnp.2005.083113","article-title":"Neuropsychiatric symptoms in patients with Parkinson\u2019s disease and dementia: frequency, profile and associated care giver stress","volume":"78","author":"Aarsland","year":"2007","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.ncl.2015.08.010_bib29","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1001\/archneurol.2010.166","article-title":"A\u00a012-year population-based study of psychosis in Parkinson disease","volume":"67","author":"Forsaa","year":"2010","journal-title":"Arch Neurol"},{"key":"10.1016\/j.ncl.2015.08.010_bib30","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1093\/brain\/123.4.733","article-title":"Hallucinations in Parkinson\u2019s disease: prevalence, phenomenology and risk factors","volume":"123","author":"Fenelon","year":"2000","journal-title":"Brain"},{"key":"10.1016\/j.ncl.2015.08.010_bib31","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1001\/archneurol.2010.65","article-title":"Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients","volume":"67","author":"Weintraub","year":"2010","journal-title":"Arch Neurol"},{"key":"10.1016\/j.ncl.2015.08.010_bib32","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1002\/ana.22164","article-title":"Amantadine use associated with impulse control disorders in Parkinson disease in cross-sectional study","volume":"68","author":"Weintraub","year":"2010","journal-title":"Ann Neurol"},{"key":"10.1016\/j.ncl.2015.08.010_bib33","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1212\/WNL.47.5.1113","article-title":"Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshops","volume":"47","author":"McKeith","year":"1996","journal-title":"Neurology"},{"issue":"Suppl 1","key":"10.1016\/j.ncl.2015.08.010_bib34","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1016\/j.parkreldis.2004.10.014","article-title":"Dementia with Lewy bodies and Parkinson\u2019s disease with dementia: are they different?","volume":"11","author":"Tsuiboi","year":"2005","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.ncl.2015.08.010_bib35","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s00401-008-0344-8","article-title":"The progression of pathology in longitudinally followed patients with Parkinson\u2019s disease","volume":"115","author":"Halliday","year":"2008","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.ncl.2015.08.010_bib36","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1093\/brain\/awr031","article-title":"Lewy-and Alzheimer-type pathologies in Parkinson\u2019s disease dementia: which is more important?","volume":"134","author":"Compta","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.ncl.2015.08.010_bib37","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1159\/000116984","article-title":"Staging of Alzheimer-related cortical destruction","volume":"33","author":"Braak","year":"1993","journal-title":"Eur Neurol"},{"key":"10.1016\/j.ncl.2015.08.010_bib38","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1093\/brain\/awf033","article-title":"Visual hallucinations in Lewy body disease relate to Lewy bodies in the temporal lobe","volume":"125","author":"Harding","year":"2002","journal-title":"Brain"},{"key":"10.1016\/j.ncl.2015.08.010_bib39","doi-asserted-by":"crossref","first-page":"3299","DOI":"10.1093\/brain\/awr225","article-title":"Testing an aetiological model of visual hallucinations in Parkinson\u2019s disease","volume":"134","author":"Gallagher","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.ncl.2015.08.010_bib40","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1093\/brain\/awt360","article-title":"Visuoperceptive region atrophy independent of cognitive status in patients with Parkinson\u2019s disease with hallucinations","volume":"137","author":"Goldman","year":"2014","journal-title":"Brain"},{"key":"10.1016\/j.ncl.2015.08.010_bib41","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1002\/mds.25873","article-title":"Psychiatric issues in cognitive impairment","volume":"29","author":"Aarsland","year":"2014","journal-title":"Mov Disord"},{"key":"10.1016\/j.ncl.2015.08.010_bib42","first-page":"192","article-title":"Is REM sleep behavior disorders (RBD) a risk factor of dementia in idiopathic Parkinson\u2019s disease?","volume":"255","author":"Marion","year":"2008","journal-title":"J\u00a0Neurol"},{"key":"10.1016\/j.ncl.2015.08.010_bib43","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1002\/mds.10417","article-title":"Sleep attacks, daytime sleepiness, and dopamine agonists in Parkinson\u2019s disease","volume":"18","author":"Paus","year":"2003","journal-title":"Mov Disord"},{"key":"10.1016\/j.ncl.2015.08.010_bib44","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1093\/brain\/awu193","article-title":"Hippocampal Lewy pathology and cholinergic dysfunction are associated with dementia in Parkinson\u2019s disease","volume":"137","author":"Hall","year":"2014","journal-title":"Brain"},{"key":"10.1016\/j.ncl.2015.08.010_bib45","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1136\/jnnp-2014-307659","article-title":"Efficacy and safety of cholinesterase inhibitors and memantine in cognitive impairment in Parkinson\u2019s disease, Parkinson\u2019s disease dementia, and dementia with Lewy bodies: systematic review with metaanalysis and trail sequential analysis","volume":"86","author":"Wang","year":"2015","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.ncl.2015.08.010_bib46","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1212\/01.WNL.0000068010.82167.CF","article-title":"Longitudinal outcome of Parkinson\u2019s disease patients with psychosis","volume":"11","author":"Factor","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2015.08.010_bib47","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1002\/mds.10176","article-title":"The effect of quetiapine on psychosis and motor function in parkinsonian patients with and without dementia","volume":"17","author":"Reddy","year":"2002","journal-title":"Mov Disord"},{"key":"10.1016\/j.ncl.2015.08.010_bib48","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1136\/jnnp.2003.029868","article-title":"Clozapine in drug induced psychosis in Parkinson\u2019s disease: a randomized, placebo controlled study with open follow up","volume":"75","author":"Pollak","year":"2004","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.ncl.2015.08.010_bib49","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1007\/s11064-014-1293-3","article-title":"On the discovery and development of pimavanserin: a novel drug candidate for Parkinson\u2019s psychosis","volume":"39","author":"Hacksell","year":"2014","journal-title":"Neurochem Res"},{"key":"10.1016\/j.ncl.2015.08.010_bib50","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1212\/WNL.0b013e3182516244","article-title":"A\u00a0randomized, double-blind, placebo-controlled trail of antidepressants in Parkinson disease","volume":"78","author":"Richard","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2015.08.010_bib51","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1001\/jamaneurol.2014.2472","article-title":"Combined rasagiline and antidepressant use in Parkinson disease in the ADAGIO study: effects on nonmotor symptoms and tolerability","volume":"72","author":"Smith","year":"2015","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.ncl.2015.08.010_bib52","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1212\/WNL.0000000000000644","article-title":"Phase I\/II randomized trial of aerobic exercise in Parkinson disease in a community setting","volume":"83","author":"Uc","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2015.08.010_bib53","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/S1474-4422(13)70123-6","article-title":"Exercise-enhanced Neuroplasticity targeting motor and cognitive circuitry in Parkinson\u2019s disease","volume":"12","author":"Petzinger","year":"2013","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.ncl.2015.08.010_bib54","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1002\/mds.25880","article-title":"Cognitive impairment in multiple system atrophy: a position statement by the Neuropsychology Task Force of the MDS Multiple System Atrophy (MODIMSA) study group","volume":"29","author":"Stankovic","year":"2014","journal-title":"Mov Disord"},{"key":"10.1016\/j.ncl.2015.08.010_bib55","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1093\/brain\/awq158","article-title":"Cognitive impairment in patients with multiple system atrophy and progressive supranuclear palsy","volume":"133","author":"Brown","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.ncl.2015.08.010_bib56","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1212\/01.wnl.0000310413.04462.6a","article-title":"Cognitive impairments in multiple system atrophy: MSA-C vs MSA-P","volume":"70","author":"Kawai","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2015.08.010_bib57","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1111\/j.1468-1331.2009.02661.x","article-title":"Cognitive deficits in multiple system atrophy correlate with frontal atrophy and disease duration","volume":"16","author":"Chang","year":"2009","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.ncl.2015.08.010_bib58","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1002\/mds.25887","article-title":"Neuropathological features of multiple system atrophy with cognitive impairment","volume":"29","author":"Asi","year":"2014","journal-title":"Mov Disord"},{"key":"10.1016\/j.ncl.2015.08.010_bib59","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.parkreldis.2013.02.012","article-title":"Clinical and imaging characteristics of dementia in multiple system atrophy","volume":"19","author":"Kim","year":"2013","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.ncl.2015.08.010_bib60","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0022-510X(96)00172-4","article-title":"Glucose metabolism in the cortical and subcortical brain structures in multiple system atrophy and Parkinson\u2019s disease: a positron emission tomographic study","volume":"144","author":"Otsuka","year":"1996","journal-title":"J\u00a0Neurol Sci"},{"key":"10.1016\/j.ncl.2015.08.010_bib61","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s00702-009-0365-z","article-title":"Cognition in multiple system atrophy: neuropsychological profile and interaction with mood","volume":"117","author":"Balas","year":"2010","journal-title":"J\u00a0Neural Transm"},{"key":"10.1016\/j.ncl.2015.08.010_bib62","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1056\/NEJMra1311488","article-title":"Multiple-system atrophy","volume":"372","author":"Fanciulli","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ncl.2015.08.010_bib63","first-page":"916","article-title":"Cognitive-behavioural features of progressive supranuclear palsy syndrome overlap with frontotemporal dementia","volume":"262","author":"Kobylecki","year":"2015","journal-title":"J\u00a0Neurol"},{"key":"10.1016\/j.ncl.2015.08.010_bib64","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1093\/arclin\/acs098","article-title":"Executive dysfunction is the primary cognitive impairment in progressive supranuclear palsy","volume":"28","author":"Gerstenecker","year":"2013","journal-title":"Arch Clin Neuropsychol"},{"key":"10.1016\/j.ncl.2015.08.010_bib65","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1479-8301.2010.00352.x","article-title":"Neuropsychiatric symptoms of progressive supranuclear palsy in a dementia clinic","volume":"11","author":"Yatabe","year":"2011","journal-title":"Psychogeriatrics"},{"key":"10.1016\/j.ncl.2015.08.010_bib66","doi-asserted-by":"crossref","first-page":"e80353","DOI":"10.1371\/journal.pone.0080353","article-title":"Are frontal cognitive and atrophy patterns different in PSP and bvFTD? A comparative neuropsychological and VBM study","volume":"8","author":"Lagarde","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ncl.2015.08.010_bib67","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1176\/jnp.13.1.42","article-title":"Neuropsychiatric symptoms of patients with progressive supranuclear palsy and Parkinson\u2019s disease","volume":"13","author":"Aarsland","year":"2001","journal-title":"J\u00a0Neuropsychiatry Clin Neurosci"},{"key":"10.1016\/j.ncl.2015.08.010_bib68","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1212\/WNL.47.5.1184","article-title":"Neuropsychiatric aspects of progressive supranuclear palsy","volume":"47","author":"Litvan","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2015.08.010_bib69","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.parkreldis.2014.05.015","article-title":"Psychiatric disturbances in patients with progressive supranuclear palsy: a case-control study","volume":"20","author":"Bloise","year":"2014","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.ncl.2015.08.010_bib70","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1136\/jnnp.2008.155846","article-title":"Emotion recognition in progressive supranuclear palsy","volume":"80","author":"Ghosh","year":"2009","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.ncl.2015.08.010_bib71","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1002\/mds.25872","article-title":"Cognition in corticobasal syndrome and progressive supranuclear palsy: a review","volume":"29","author":"Burrell","year":"2014","journal-title":"Mov Disord"},{"key":"10.1016\/j.ncl.2015.08.010_bib72","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1136\/jnnp.65.5.717","article-title":"Neuropsychiatric features of corticobasal degeneration","volume":"65","author":"Litvan","year":"1998","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"}],"container-title":["Neurologic Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733861915000857?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733861915000857?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T17:42:09Z","timestamp":1567359729000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0733861915000857"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":72,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["S0733861915000857"],"URL":"https:\/\/doi.org\/10.1016\/j.ncl.2015.08.010","relation":{},"ISSN":["0733-8619"],"issn-type":[{"value":"0733-8619","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cognitive and Psychiatric Disturbances in Parkinsonian Syndromes","name":"articletitle","label":"Article Title"},{"value":"Neurologic Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ncl.2015.08.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}